antisense oligonucleotide targeting thrombopoietin (Ionis Pharmaceuticals/Oregon Health Science University/Aronora)

N/A

Report date: 2025/03/14 16:29:22
NME

Base Information

Drug Nameantisense oligonucleotide targeting thrombopoietin (Ionis Pharmaceuticals/Oregon Health Science University/Aronora)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionThrombopoietin receptor inhibitors
TargetsThrombopoietin receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health And Science UniversityIonis Pharmaceuticals IncAronora Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A